new drug approval dapagliflozin (farxiga)
DESCRIPTION
SGLT2- InhibitorTRANSCRIPT
New Drug Approval
1. Drug Name: Dapagliflozin (Farxiga)
2. Company Name: Bristol-Meyers Squibb Company, Princeton, N.J. and
AstraZeneca Pharmaceuticals L.P., Wilmington, Del.
3. Approval Body: U.S. Food and Drug Administration (U.S. FDA)
4. Where the drug was marketing: Wilmington.
5. Date of Approval: Jan. 8, 2014
REFERENCE:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm380829.htm